Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings

Top spenders & firms Spend by issue

Clear
Q2
SALT POINT STRATEGIES for VERTEX PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $30,000.00 income
Pharmacy
View →
Q2
BALLARD PARTNERS for NATIONAL ASSOCIATION OF CHAIN DRUG STORES
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate · $90,000.00 income
Health Issues, Pharmacy
View →
Q2
VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations
View →
Q2
SQUIRE PATTON BOGGS for SK AMERICAS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New York · House · Senate · $180,000.00 income
Taxation/Internal Revenue Code, Trade (domestic/foreign), Environment/Superfund, Pharmacy
View →
Q2
PORT SIDE STRATEGIES, LLC for SOCIAL SECURITY WORKS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $20,000.00 income
Retirement, Medicare/Medicaid, Government Issues, Budget/Appropriations
View →
Q2
PORT SIDE STRATEGIES, LLC for CENTER FOR HEALTH AND DEMOCRACY
2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate · $20,000.00 income
Medicare/Medicaid, Health Issues, Pharmacy, Budget/Appropriations
View →
RR
LMH STRATEGIC SOLUTIONS for INCYTE CORPORATION
3rd Quarter (July 1 - Sep 30) 2025 · Delaware
Pharmacy, Medicare/Medicaid
View →
RR
LMH STRATEGIC SOLUTIONS for HARMONY BIOSCIENCES
3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania
Pharmacy, Medicare/Medicaid
View →
RR
LMH STRATEGIC SOLUTIONS for EXELIXIS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California
Pharmacy, Medicare/Medicaid
View →
RR
LMH STRATEGIC SOLUTIONS for ARDELYX, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California
Pharmacy, Medicare/Medicaid
View →
RR
LMH STRATEGIC SOLUTIONS for NEUROCRINE BIOSCIENCES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California
Medicare/Medicaid, Pharmacy
View →
RR
LMH STRATEGIC SOLUTIONS for BIOMARIN PHARMACEUTICAL, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California
Medicare/Medicaid, Pharmacy
View →
RR
LMH STRATEGIC SOLUTIONS for ACADIA PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2025 · California
Medicare/Medicaid, Pharmacy
View →
Q2
LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q2
LMH STRATEGIC SOLUTIONS for GLAXOSMITHKLINE LLC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues, Pharmacy
View →
Q2
LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS, PLC
2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $60,000.00 income
Pharmacy
View →
RR
DA VINCI GROUP for PROCARE, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Georgia
Pharmacy
View →
Q2
KOUNTOUPES DENHAM CARR & REID, LLC for AMERICAN KRATOM ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate · $50,000.00 income
Consumer Issues/Safety/Products, Health Issues, Pharmacy, Budget/Appropriations
View →
Q2
AMERICAN SOCIETY OF CONSULTANT PHARMACISTS for AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q2
THE ROTUNDA GROUP LLC for HEALTHPLAN DATA SOLUTIONS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Ohio · House · $10,000.00 income
Pharmacy
View →
Q2
AMERICAN PHARMACISTS ASSOCIATION for AMERICAN PHARMACISTS ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy
View →
RR
THE KPM GROUP DC LLC for INOZYME PHARMA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts
Pharmacy
View →
Q2
THE HARPLE GROUP, LLC for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION (PILMA)
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate · $30,000.00 income
Pharmacy
View →
Q2
WAXMAN STRATEGIES for 340B HEALTH
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $39,000.00 income
Health Issues, Pharmacy
View →
Q2
WAKEFERN FOOD CORP. for WAKEFERN FOOD CORP.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Pharmacy, Law Enforcement/Crime/Criminal Justice, Agriculture, Financial Institutions/Investments/Securities
View →
Previous Page 57 of 72 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem